beta-amyloid deposition inhibitors (Elan)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namebeta-amyloid deposition inhibitors (Elan)
Drug Alias Name(+)-gossypol (Elan)beta-amyloid aggregation inhibitors (Elan)AN-11971AN-45924
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElan Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElan Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A